**Health**
# Covid Inquiry Reveals Former Health Secretary Overlooked Critical Advice on Universal NHS Testing
In a significant revelation at the ongoing UK Covid-19 Inquiry, evidence has surfaced indicating that former Health Secretary Matt Hancock disregarded urgent warnings from two of the world’s most distinguished scientists regarding the testing of NHS personnel.
Nobel Prize winners Sir Paul Nurse and Sir Venki Ramakrishnan reportedly urged the government to implement universal testing for all healthcare workers to mitigate the risk of “asymptomatic transmission”—a call that remained unheeded during a critical phase of the pandemic’s initial surge.
### The Warning from the Scientific Elite
The inquiry heard that Sir Paul Nurse, Director of the Francis Crick Institute, and Sir Venki Ramakrishnan, then-President of the Royal Society, grew increasingly concerned about the silent spread of the virus within clinical settings. Their primary anxiety centered on the fact that healthcare staff could inadvertently transmit the virus to highly vulnerable patients while showing no symptoms themselves.
Despite their international standing and the gravity of their concerns, their recommendation to test all NHS staff—regardless of symptoms—was met with resistance or delay. At the time, official policy focused predominantly on testing only those already displaying symptoms, a strategy the scientists argued was insufficient to protect the integrity of the healthcare system.
### Asymptomatic Transmission: The Missing Link
The concept of asymptomatic transmission became one of the most contentious points of the early pandemic response. While the scientific community increasingly pointed toward evidence that individuals could spread the virus without feeling ill, the political response lagged.
According to testimony, the failure to adopt a universal testing mandate for staff may have contributed to “nosocomial” infections—cases where patients contracted the virus while already in the hospital for other treatments. The Nobel laureates emphasized that frequent, systematic testing of the workforce was the only viable “firebreak” to prevent hospitals from becoming vectors for the disease.
### Implications for Public Health Policy
The testimony adds to a growing body of evidence being scrutinized by the inquiry regarding the friction between scientific advice and political decision-making. Critics argue that the delay in implementing widespread testing not only endangered frontline staff but also compromised patient safety during a period of extreme national crisis.
For the medical community, the revelations underscore the vital importance of transparency and the rapid integration of high-level scientific expertise into executive policy. The inquiry continues to examine whether the “blind spot” regarding asymptomatic spread was a result of limited testing capacity or a failure of leadership to grasp the evolving science.
### Looking Ahead
As the Covid-19 Inquiry proceeds, these findings serve as a stark reminder of the complexities of pandemic management. The testimony of Sir Paul Nurse and Sir Venki Ramakrishnan highlights a pivotal moment where specialized knowledge met political inertia, providing a case study for future public health preparedness.
The inquiry’s final report is expected to offer definitive recommendations on how governments should handle conflicting data and expert warnings in the face of future global health threats.
